ERBB2 and breast carcinoma: Similarly, NF-κB activity in breast cancer metastasis are likely induced by infiltrating T-cells [16] in contrast to the cell autonomous activation of NF-κB downstream of Src [41], Her2 [42] or by mutation of p53 [43].